New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market GrowthPALM BEACH, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The SARS-CoV-2, literally affected the whole world in these past years and has increased a global search for therapies and treatments. A report from Transparency Market Research said that: “the emergence of new variants of coronavirus will boost COVID-19 therapeutics market growth. Demand for drugs that can effectively treat new strains of the virus is likely to be significantly high, as these new variants may be less susceptible to existing therapeutics. This is projected to boost the COVID-19 therapeutics market size, as pharmaceutical companies race to develop new drugs and treatments to address these new variants. Even after the pandemic is under control, there would still be a need for treatments and therapies to help those who have been affected by the virus, including those with long-term effects. This is anticipated to continue to drive COVID-19 therapeutics market demand. Additionally, emergence of new variants of the virus and the possibility of future outbreaks are anticipated to prompt governments and private organizations to be better prepared for future pandemics.” Active companies in the biotech industry this week include Sunshine Biopharma Inc. (NASDAQ:
SBFM), Novavax, Inc. (NASDAQ:
NVAX), REGENXBIO Inc. (NASDAQ:
RGNX), BIONTECH SE (NASDAQ:
BNTX), Abbvie (NYSE:
ABBV).
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVIDPalm Beach, FL – November 17, 2022 – FinancialNewsMedia.com News Commentary – Since the beginning of the pandemic, the critical effort of researchers is to understand how coronavirus damages the body. Research and development is still focused on trying to help understand the acute infection 9itself and the effects of long COVID as well. As debilitating as […]
